PetVivo Holdings, Inc. Announces They Are Exhibiting at Western Veterinary Conference

Minneapolis, MN -- January 28, 2020 -- InvestorsHub NewsWire -- PetVivo Holdings, Inc. (OTCQB: PETV) (the "Company") PetVivo Holdings, Inc. (www.petvivo.com) an emerging biomedical device company operating in the $18B veterinary market announced today it will be exhibiting at the Western Veterinary Conference from February 16th to February 19th, 2020 at the Mandalay Bay Convention Center in Las Vegas, NV.

PetVivo is excited to meet with many of the 15,000+ participants to talk about its lead product, an injection of sterilized, hydrogel microparticles that are wet, slippery and spongy for the treatment of osteoarthritis and lameness originating in the joints of dogs and horses. WVC is one of the largest veterinary conferences in the United States and plays host to many of the industry's top professionals.

"We at PetVivo are excited to network with leaders in the industry and develop relationships that will help drive our product forward," said John Lai, CEO of PetVivo Holdings, Inc.

For more information about PetVivo, please contact info1@petvivo.com or visit https://petvivo.com/

Conference Details:

Western Veterinary Conference (WVC) Booth #: 4439

Dates:

Monday, February 17, 2020 9:00am – 6:00pm
Tuesday, February 18, 2020 9:00am – 6:00pm
Wednesday, February 19, 2020 9:00am – 2:00pm

About PetVivo Holdings, Inc.

PetVivo Holdings, Inc. (OTCQB: PETV) is an emerging veterinary biomedical company focused on licensing and commercialization of highly innovative medical technologies for companion animal therapeutics. PetVivo is leveraging investments made in the human medical device industry to commercialize therapeutics for pets in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, and the opportunity to bring products into large markets represented by currently unmet needs of our companion animals.

Forward-Looking commercial Statements:

The foregoing material may contain forward-looking statements. We caution that such statements may be subject to uncertainties and that actual results could differ materially from the forward-looking statements. Readers accordingly should not place undue reliance on these forward-looking statements, which do not reflect unknown or unanticipated events or circumstances occurring after the date of these forward-looking statements

CONTACT:
John Lai
President & CEO
PetVivo Holdings, Inc.
Main: 952-405-6216